🇺🇸 FDA
Pipeline program

DT-DEC01

DT-DEC01-DMD-CT-1/2

Phase 2 small_molecule active

Quick answer

DT-DEC01 for Duchenne Muscular Dystrophy is a Phase 2 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
Ology Bioservices Ireland LTD
Indication
Duchenne Muscular Dystrophy
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials